LYON, France, April 14, 2011 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that the European Union's Eurostars Program has awarded Euro 1.1 million to the Consortium research cooperation program comprised of project leader Epitarget AS, a Norwegian Company, French academic laboratory INSERM, and EDAP. The funds will be used to accelerate the transfer of the program's ultrasound triggered drug delivery technology from laboratory to patient.
